Regulatory Strategy for SaMD Registration in Europe
Building on a firm regulatory foundation is essential for sustained success in the European Union’s rapidly evolving digital health landscape. As Software as a Medical Device (SaMD) adoption accelerates across AI-driven diagnostics, clinical decision support software, and remote monitoring, regulators are tightening expectations under EU MDR, EU IVDR, and the EU AI Act. Successfully entering the EU market now requires a forward-looking regulatory strategy grounded in deep, current understanding of European SaMD requirements.
For manufacturers and MedTech businesses, this environment presents both opportunity and complexity. Achieving SaMD registration in Europe involves navigating MDR Rule 11 Risk classification, conformity assessment pathways, CE marking, EUDAMED SaMD registration, and ongoing post-market surveillance. Increased scrutiny around clinical evidence, cybersecurity, and lifecycle management means that gaps in documentation or strategy can lead to delays, higher costs, or loss of market continuity.
Freyr helps manufacturers address these challenges through end-to-end EU-focused SaMD regulatory support. Our experts guide companies from initial regulatory strategy through SaMD CE marking and long-term compliance, applying a practical, risk-based approach aligned with EU MDR and emerging AI regulations. This enables confident, efficient market entry and sustained compliance across the SaMD product lifecycle in Europe.
Digital Health & SaMD Regulatory Services for EU
Our regulatory services are crafted to support you across the entire lifecycle of your Digital Health or Software as a Medical Device (SaMD) product in the European market, delivering comprehensive EU Medical Device Regulation SaMD support and SaMD registration in Europe, including:
![]()
Regulatory Strategy & Planning
Tailored pathways to SaMD registration in the Europe and EU MDR compliance, based on your product’s risk class, intended use, innovation profile, and MDR Rule 11 SaMD classification considerations (e.g., software updates, AI enabled features).
![]()
Conformity & CE Marking Support
End-to-end support for the SaMD CE marking process, including preparation and maintenance of technical documentation under Medical Device Software EU MDR and IVDR, selection of appropriate conformity assessment routes, and coordination with a Notified Body for SaMD CE marking, where applicable.
![]()
EU AI Act Compliance
Expert guidance on AI system classification, risk assessment, and alignment with transparency, governance, and documentation requirements under the EU AI Act, integrated with Software as a Medical Device EU regulation obligations.
![]()
Quality & Compliance Support
Advisory services for implementing and maintaining EU MDR compliance services, including Quality Management System (QMS) implementation, cybersecurity risk management, software lifecycle validation, interoperability, vigilance obligations, and Regulatory readiness for audits and inspections.
![]()
Clinical/Performance Evaluation & Validation
Support for SaMD conformity assessment , including the design and execution of clinical evaluation or performance studies, real world data strategies, usability and human factors assessments, and generation of robust safety and performance evidence.
![]()
Post Market Surveillance & Vigilance
Ongoing compliance support following SaMD registration in EU, including safety signal monitoring, complaint handling, trend analysis, PSUR (Periodic Safety Update Report) preparation, and corrective and preventive action (CAPA) management to sustain long term EU market access.
![]()
Regulatory Intelligence & Monitoring
Continuous monitoring of evolving Software as a Medical Device in EU, including updates to EU MDR Software as medical device compliance requirements, IVDR guidance, EU AI Act developments, harmonized standards, common specifications, and competitor and procedural intelligence relevant to Digital Health and Software as a Medical Device (SaMD) manufacturers.
![]()
Consulting & Advisory
Expert SaMD Regulatory consultancy in EU supporting risk management activities, SaMD EU MDR gap assessments, software change control and impact analysis under MDR Rule 11 SaMD classification, labeling and UDI strategies, audit preparation, and inspection readiness for EU MDR SaMD registration services
With our deep European regulatory expertise and comprehensive EU MDR SaMD support, you gain a trusted partner that helps reduce Regulatory risk, accelerate registration process , and ensure sustained compliance throughout the product lifecycle as EU laws, standards, and guidance continue to evolve.
SaMD & Digital Health Case Study
Explore Freyr’s Regulatory Services for SaMD & Digital Health.
Book a meeting with our experts today
- Schedule a call today
Why Partner with Freyr?
- Proven throughput with 150+ global SaMD approvals, including high risk and AI driven software solutions.
- Enable smooth EU and UK market access with reliable EAR, UKRP, and CH-Rep services.
- Robust EU MDR/IVDR Regulatory strategy tailored to SaMDs, supporting compliance across the product lifecycle.
- Benefit from Regulatory and market intelligence expertise to navigate evolving global requirements with confidence.
- Ensure accurate SaMD classification and efficient registrations, reducing Regulatory risk and time to market.
- Strengthen submissions with end-to-end support for SaMD development and technical documentation.
- Leverage expert guidance on SaMD clinical evaluation and evidence generation.
- Maintain compliance through streamlined post-approval change management.
Frequently Asked Questions
01. How does software qualify as a Medical Device in the EU?
Software qualifies as Medical Device Software (MDSW) under Medical Device Software EU MDR when the manufacturer intends it for medical purposes such as diagnosis, monitoring, or treatment, making it Software as a Medical Device (SaMD) under Software as a Medical Device in EU. Software that only drives hardware is classified as SiMD.
02. What is the difference between MDSW, SaMD, and SiMD?
Software as a Medical Device (SaMD) is standalone software performing medical functions under Software as a Medical Device EU regulation. Medical Device Software (MDSW) is the EU MDR umbrella term covering SaMD and embedded software. Software in a Medical Device (SiMD) is software that controls or drives a physical medical device under Medical Device Software EU MDR.
03. What are the EU MDR classification rules for SaMD?
Under EU medical device compliance, SaMD is classified according to intended purpose and risk, primarily using MDR Rule 11 SaMD classification. Lower risk software may fall into Class I, while software influencing diagnosis or treatment decisions is typically Class IIa, IIb, or III, requiring appropriate SaMD Regulatory services in the EU.
04. How long does it take to get a SaMD approved in the EU?
The timeline for SaMD registration in the Europe depends on classification, documentation readiness, and Notified Body availability. Class I SaMD may take three to six months, while higher risk devices requiring Notified Body SaMD CE marking typically take nine to eighteen months or longer. Early planning supports faster EU MDR SaMD compliance.
05. What are the key steps to register a SaMD in the EU?
SaMD registration in the Europe starts with MDR Rule 11 SaMD classification, followed by SaMD conformity assessment, technical documentation, and clinical or performance evaluation. Manufacturers must implement an ISO 13485 QMS, complete the SaMD CE marking process, and finalize EU SaMD registration steps, with ongoing post market surveillance to maintain EU MDR SaMD compliance.
06. What role does the EU AI Act play for AI based SaMD?
The EU AI Act establishes a harmonized framework for AI based Software as a Medical Device, directly impacting SaMD compliance. AI driven SaMDs typically fall under high risk classification, requiring alignment with EU MDR compliance, MDR Rule 11 SaMD classification, risk management, transparency, and post-market controls to support the CE marking process and SaMD conformity assessment.
07. What are post-market obligations for SaMD in the EU?
Post-market obligations for SaMD in the EU include continuous post-market surveillance, vigilance reporting, periodic safety update reports (PSURs), clinical follow-up where applicable, cybersecurity monitoring, and timely updates in EUDAMED. Manufacturers must actively assess real-world performance, manage software changes, and ensure ongoing compliance with EU MDR and relevant MDCG guidance throughout the product lifecycle.
08. Why is Freyr considered a trusted partner for SaMD registration in Europe?
Freyr is widely recognized for its deep expertise in EU MDR software regulations, MDR Rule 11 classification, CE marking, and post-market compliance for Software as a Medical Device. By combining EU-specific regulatory knowledge with practical, risk-based execution and lifecycle support, Freyr helps manufacturers achieve efficient SaMD registration in Europe and maintain long-term regulatory confidence.
